Kamran Hosseini | Biochemistry | Best Researcher Award

Published on by Academic Achievements

Best Researcher Award

Kamran Hosseini
Affiliation Shiraz University of Medical Sciences
Country Iran
Scopus ID 57226155096
Documents 32
Citations 638
h-index 10
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Achievements & Awards
ORCID 0000-0003-1189-7143

Kamran Hosseini
Shiraz University of Medical Sciences, Iran

The Best Researcher Award recognizes distinguished scholars whose sustained scientific achievements, publication record, research quality, and academic influence demonstrate excellence within their respective disciplines. Kamran Hosseini has established an active research profile in biochemistry, genetics, molecular biology, neuroscience, and clinical medicine through peer-reviewed publications addressing neurological disorders, molecular signaling pathways, spinal surgery, and translational biomedical research.[1] His scholarly output, citation impact, and international visibility provide evidence of continued contributions to medical science and interdisciplinary biomedical research.[2]

Abstract

Kamran Hosseini has contributed to contemporary biomedical research through investigations spanning molecular biology, neurology, neurosurgery, gene therapy, spinal disorders, and translational medicine. His publication portfolio demonstrates interdisciplinary collaboration while integrating laboratory discoveries with clinical applications. Current research includes viral vector-mediated therapeutic strategies, spinal surgery outcomes, neurological disease mechanisms, and complex neurosurgical case management.[3] Such work reflects sustained engagement with evidence-based medicine and translational biomedical science.

Keywords

Best Researcher Award, Kamran Hosseini, Neuroscience, Molecular Biology, Gene Therapy, AAV Vectors, Biochemistry, Genetics, Neurosurgery, Clinical Research, Biomedical Science, Translational Medicine, Shiraz University of Medical Sciences.

Introduction

Recognition through a Best Researcher Award is commonly based upon sustained scholarly productivity, measurable research impact, publication quality, interdisciplinary collaboration, and contributions to scientific advancement. Researchers working across molecular biology and clinical medicine play an important role in translating laboratory discoveries into practical healthcare improvements.[1] Kamran Hosseini’s research activities illustrate this translational approach by integrating basic biological science with clinical neurosurgical investigations.

Research Profile

  • Affiliation: Shiraz University of Medical Sciences
  • Primary discipline: Biochemistry, Genetics and Molecular Biology
  • Scopus documents: 32
  • Total citations: 638
  • Scopus h-index: 10
  • Research interests include neuroscience, molecular signaling pathways, neurosurgery, spinal disorders, translational medicine, and gene therapy.

Research Contributions

The research portfolio demonstrates contributions across molecular neuroscience, neurological disorders, spinal surgery, and clinical case studies. Recent investigations evaluate adeno-associated virus (AAV) vectors for therapeutic modulation of cellular signaling pathways, assess perioperative interventions to reduce blood loss during spinal fusion procedures, and document rare neurosurgical cases that contribute to evidence-based clinical decision making.[3] These publications illustrate interdisciplinary collaboration between molecular biology and clinical neuroscience while supporting translational healthcare research.

Publications

  • AAV Vector‐Mediated Modulation of Signaling Pathways in Neurological Disorders, Cell Biochemistry and Function (2026). DOI: 10.1002/cbf.70270.
  • Prophylactic effects of tranexamic acid in spinal fusion, Egyptian Journal of Neurosurgery (2026). DOI: 10.1186/s41984-026-00560-8.
  • Giant Lumbosacral Meningioma Without Dural Attachment in an Adolescent, International Medical Case Reports Journal (2026). DOI: 10.2147/IMCRJ.S578462.
  • Management of Intrathoracic Huge Meningocele in Neurofibromatosis Type-1, International Medical Case Reports Journal (2026). DOI: 10.2147/IMCRJ.S578419.
  • Kümmell’s Disease in Benign Vertebral Compression Fractures, Clinical Neurology and Neurosurgery (2026). DOI: 10.1016/j.clineuro.2025.109262.

Research Impact

Available bibliometric indicators demonstrate an established publication record comprising 32 indexed documents, 638 citations, and an h-index of 10. These metrics indicate continued scholarly engagement and measurable scientific visibility within biomedical research.[1] The combination of molecular biology, neuroscience, and clinical investigations contributes to interdisciplinary knowledge relevant to both research laboratories and healthcare practice.

Award Suitability

Based on the available academic profile, publication activity, citation performance, interdisciplinary research scope, and contributions to peer-reviewed biomedical literature, Kamran Hosseini demonstrates characteristics commonly evaluated for academic recognition programs such as the Best Researcher Award. His research integrates molecular science with clinical application while contributing to neurological disease research, spinal surgery, and translational medicine through internationally published scientific work.[2]

Conclusion

Kamran Hosseini’s scholarly record reflects sustained participation in biomedical research characterized by interdisciplinary collaboration, clinically relevant investigations, and measurable academic impact. His publication portfolio, citation metrics, and recent contributions to neuroscience and molecular biology illustrate a research trajectory aligned with internationally recognized standards of scientific excellence and make his profile appropriate for consideration within academic recognition initiatives.

References

  1. Elsevier. (n.d.). Scopus author details: Kamran Hosseini, Author ID 57226155096. Scopus.
    https://www.scopus.com/pages/authors/57226155096
  2. ORCID. (n.d.). Kamran Hosseini ORCID Record.
    https://orcid.org/0000-0003-1189-7143
  3. Hosseini K. et al. (2026). AAV Vector‐Mediated Modulation of Signaling Pathways in Neurological Disorders: Insights From Cellular, Animal, and Human Studies. Cell Biochemistry and Function. DOI: https://doi.org/10.1002/cbf.70270
  4. Hosseini K. et al. (2026). Prophylactic effects of tranexamic acid in spinal fusion. Egyptian Journal of Neurosurgery. https://doi.org/10.1186/s41984-026-00560-8
  5. Recent peer-reviewed publications in International Medical Case Reports Journal and Clinical Neurology and Neurosurgery (2026). https://doi.org/10.2147/IMCRJ.S578462

Monika Bhadauria | Hepatoprotection | Distinguished Scientist Award

Published on by Academic Achievements

Prof. Monika Bhadauria | Hepatoprotection | Distinguished Scientist Award 

Prof. Monika Bhadauria | Hepatoprotection | Professor at Guru Ghasidas University | India

Prof. Monika Bhadauria is a distinguished academic and researcher in the Department of Zoology at Guru Ghasidas University, India, with over two decades of extensive experience in teaching, research, and administration. She earned her Ph.D. from Jiwaji University, focusing on hepatoprotective evaluation of natural products, after completing her M.Sc. and B.Sc. degrees with distinction in zoology and related life sciences. Prof. Bhadauria has held progressive academic appointments including Professor, Associate Professor, and Assistant Professor, alongside research fellowships and postdoctoral experience at Lanzhou University, China. Her primary research interests encompass hepatoprotection, environmental toxicology, pharmacology, neurobiology, medicinal plant therapeutics, and obesity regulation, with advanced skills in experimental design, in vivo and in vitro studies, biochemical analysis, and translational research. She has contributed significantly to national and international research projects funded by DST, UGC, DBT, and CSIR, leading studies on anti-tuberculosis drug-induced hepatic abnormalities, resveratrol and curcumin effects, and chemical characterization of propolis for therapeutic applications. Prof. Bhadauria has an impressive record of 55 documents, 1,380 citations, and an H-index of 22, reflecting the high impact of her work published in reputed journals. She has received numerous awards and recognitions including Outstanding Scientist Award, Best Science Research Award, Junior Scientist Award, and Young Scientist Awards from various national and international organizations. Beyond research, she has contributed to academic governance and leadership as Head of Department, Chairman of Board of Studies, member of research advisory committees, and convenor of several university-level committees, while also serving as editor and peer reviewer for multiple journals including Flora and Fauna, Experimental and Toxicologic Pathology, and Journal of Applied Biomedicine. Her professional memberships include the Indian Science Congress Association and the Society of Toxicology (STOX). Prof. Bhadauria’s career demonstrates a strong commitment to advancing scientific knowledge, mentoring students, and bridging research with societal impact. She is widely recognized for her dedication to promoting environmental health, hepatoprotection, and life science education. With her robust expertise, leadership, and international exposure, Prof. Monika Bhadauria continues to set a benchmark in research and academia, positioning herself as a global contributor to the life sciences.

Profile: Scopus | ORCID

Featured Publications

  1. Bhadauria, M. (2015). Neurobiology of obesity regulation and therapeutic interventions. Journal of Environmental Toxicology, 12, 45–58. [Cited 120 times]

  2. Bhadauria, M. (2014). Chemical characterization of Indian propolis and evaluation of hepatoprotective effects. Pharmacology and Therapeutics, 8, 112–126. [Cited 98 times]

  3. Bhadauria, M. (2013). Anti-tuberculosis drugs induced hepatic abnormalities and protective potential of natural compounds. Environmental Toxicology and Pharmacology, 7, 67–81. [Cited 87 times]

  4. Bhadauria, M. (2012). Hepatoprotective evaluation of natural products on experimental liver injury in rats. Journal of Applied Biomedicine, 5, 33–49. [Cited 110 times]

  5. Bhadauria, M. (2011). Resveratrol, curcumin, and emodin against high-fat diet and alcohol-induced hepatorenal abnormalities. Experimental and Toxicologic Pathology, 3, 21–37. [Cited 95 times]

 

Salma Khan | Translational Research | Best Academic Researcher Award

Published on by Academic Achievements

Dr. Salma Khan | Translational Research | Best Academic Researcher Award

Dr. Salma Khan | Translational Research – Associate Professor at Loma Linda University, United States

Dr. Salma Khan is an accomplished physician-scientist and Associate Professor at Loma Linda University, with joint appointments in the School of Medicine, Internal Medicine, and Otolaryngology. With a professional journey spanning over three decades across multiple continents, she is recognized for her interdisciplinary contributions to gynecologic oncology, thyroid cancer research, and molecular medicine. A consistent advocate for diversity, equity, and mentorship, Dr. Khan has made an indelible impact through her clinical acumen, scientific innovation, and unwavering commitment to education and public health.

Academic Profile

Google Scholar  |  ORCID

Education

Dr. Khan’s academic path began with her MBBS/MD degree from Gandhi Medical College, India, followed by a residency in Obstetrics and Gynecology at the Institute of Postgraduate Medicine and Research in Bangladesh. She further advanced her specialization through a fellowship and later a PhD in Gynecologic Oncology at Kumamoto University, Japan. Her rigorous training across diverse medical cultures laid a strong foundation for her translational and community-oriented research. Early recognitions such as the Monbusho Scholarship from the Japanese government and national academic honors in Bangladesh and India highlight her longstanding dedication to academic excellence.

Experience

Over the years, Dr. Khan has seamlessly combined clinical service, research, and academia. She has served in numerous medical institutions, beginning as a staff physician in both Bangladesh and India before moving into advanced research roles in Japan and the United States. Her postdoctoral appointments at Cedars-Sinai Medical Center laid the groundwork for her transition into molecular oncology, which she continued to pursue at Loma Linda University. Rising from Postdoctoral Fellow to Assistant Research Professor, she currently holds multiple Associate Professorships at LLU and contributes significantly to graduate mentorship and faculty governance. Her leadership roles include serving as Vice-Chair of the University Faculty Council and Chair of the Basic Science Symposium Committee.

Research Interests

Dr. Khan’s research lies at the interface of molecular oncology, gynecologic malignancies, and thyroid cancer disparities. She explores novel biomarkers, immune microenvironments, and personalized treatment strategies for aggressive cancers, particularly within underserved populations. She integrates AI and nanotechnology in her work, advancing precision oncology. Her current focus includes microRNA signatures in ovarian cancer, racial disparities in thyroid cancer outcomes, and cellular morphometrics through digital pathology. She is also deeply involved in exploring the role of vitamin D in cancer prevention, especially among minority groups.

Awards

Dr. Khan’s distinguished service and impactful research have earned her multiple accolades. These include the 2025 and 2023 Best Mentor Awards from BMANA, Best Basic Science Research Award at the 2024 Annual Symposium, and several travel awards from the American Thyroid Association (ATA). Notably, she received the AACR Health Disparities Women Cancer Research Award in 2024 and the Outstanding Poster Award from the Endocrine Society in 2015. Her scholarly trajectory has been consistently supported through prestigious early-career scholarships and recognitions from international academic bodies.

Publications 📚

  1. Targeting Surface Markers in Anaplastic Thyroid Cancer (2025, Journal of the Endocrine Society) – cited by 8 articles 🔬.
  2. Mutational Landmarks in Anaplastic Thyroid Cancer (2025, Journal of Clinical Medicine) – cited by 10 articles 🧬.
  3. AI-Driven Morphometric Biomarkers in Ovarian Cancer of African Ancestry (2025, Molecular Cancer Research, under review) 🤖🧫.
  4. Silver Nanoparticles and DNA Condensation (2025, Journal of Nanoparticle Research) – exploring nanotechnology applications in cancer therapy 🧪.
  5. Vitamin D Signaling in Liver Cancer: A Review (2025, Journal of BMANA) – investigating preventive pathways 🌞🧠.
  6. Colorectal Cancer and Vitamin D Metabolic Pathways (2024, Disease & Research) – cited by 6 articles 🧬💊.
  7. MicroRNA Signatures in Serous Ovarian Carcinoma (2024, Trends in Cancer Research) – cited by 9 articles 🧬📈.

Conclusion

Dr. Salma Khan exemplifies excellence in translational cancer research, academic leadership, and community engagement. Her career reflects a synthesis of clinical compassion and molecular precision, driven by a global perspective. Through groundbreaking publications, impactful mentorship, and leadership in professional organizations such as the American Thyroid Association and AACR, she continues to shape the future of oncological science and inclusive healthcare. Her unwavering commitment to research innovation, health equity, and mentorship renders her a distinguished candidate for any award recognizing scientific and academic leadership.